#datascience #centralizedmonitoring #clinicaltrials #technologyinpharma #pharmatransformation
In this episode, Jennifer Krohn, Associate Director of Risk-Based Quality Management at Gilead Sciences, shares how centralized monitoring is transforming clinical trial oversight, improving data quality, participant safety, and trial efficiency. From statistical tools and open-source innovation to CRA training and AI advancements, Jenn shares what it takes to detect critical data signals earlier, ensure trial integrity, and foster cross-functional collaboration in pharma through the open-source community.
Materials shared in the episode:
PHUSE
RBQM Working GroupRBQM Education ProjectPHUSE CM White Papers:
Jennifer Krohn
https://www.linkedin.com/in/jenn-krohn/ Nat Chrzanowska
https://www.linkedin.com/in/nat-chrzanowska/ __________________________________________
More about Appsilon:
►
https://www.appsilon.com/Appsilon empowers pharmaceutical and life sciences companies to leverage open-source technology for faster, data-driven decision-making in regulated environments.
Schedule a free consultation with our expert ►
https://www.appsilon.com/contact-us_________________________________________
For more insights about how technology helps scientists push the boundaries of data analysis and reporting check out our blog:
►
http://appsilon.com/blog LinkedIn:
https://www.linkedin.com/company/appsilon/